<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>69(10)</volume><submitter>Algodi M</submitter><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>The optimal perioperative management of patients chronically using renin-angiotensin system inhibitors (RASIs) is still uncertain. This study aims to compare the outcomes of withholding versus continuing RASIs before surgery, focusing on efficacy and safety.&lt;h4>Methods&lt;/h4>A systematic review and meta-analysis synthesising evidence from randomised controlled trials (RCTs) obtained from PubMed, CENTRAL, Scopus, and Web of Science until September 2024. Using Stata MP v. 17, we used the fixed-effects model to report dichotomous outcomes by using the risk ratio (RR) with a 95% confidence interval (CI).&lt;h4>Results&lt;/h4>Ten RCTs with 3,740 patients were included. There was no statistical difference between both groups regarding the incidence of major adverse cardiac ev</pubmed_abstract><journal>Indian journal of anaesthesia</journal><pagination>984-998</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12445768</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Stopping versus continuing renin-angiotensin system inhibitors before surgery: An updated systematic review and meta-analysis of randomised controlled trials.</pubmed_title><pmcid>PMC12445768</pmcid><pubmed_authors>Al-Sagban A</pubmed_authors><pubmed_authors>Albayyaa M</pubmed_authors><pubmed_authors>Hashim HT</pubmed_authors><pubmed_authors>Saab O</pubmed_authors><pubmed_authors>Al-Obaidi AD</pubmed_authors><pubmed_authors>Al-Hemyari B</pubmed_authors><pubmed_authors>Algodi M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Stopping versus continuing renin-angiotensin system inhibitors before surgery: An updated systematic review and meta-analysis of randomised controlled trials.</name><description>&lt;h4>Background and aims&lt;/h4>The optimal perioperative management of patients chronically using renin-angiotensin system inhibitors (RASIs) is still uncertain. This study aims to compare the outcomes of withholding versus continuing RASIs before surgery, focusing on efficacy and safety.&lt;h4>Methods&lt;/h4>A systematic review and meta-analysis synthesising evidence from randomised controlled trials (RCTs) obtained from PubMed, CENTRAL, Scopus, and Web of Science until September 2024. Using Stata MP v. 17, we used the fixed-effects model to report dichotomous outcomes by using the risk ratio (RR) with a 95% confidence interval (CI).&lt;h4>Results&lt;/h4>Ten RCTs with 3,740 patients were included. There was no statistical difference between both groups regarding the incidence of major adverse cardiac ev</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-05-03T03:21:19.459Z</modification><creation>2026-05-03T03:12:30.734Z</creation></dates><accession>S-EPMC12445768</accession><cross_references><pubmed>40979762</pubmed><doi>10.4103/ija.ija_416_25</doi></cross_references></HashMap>